Podcasts about drug information

Information on COVID vaccines is moving fast. On May 27th, HHS Secretary Robert F. Kennedy Jr. announced that COVID vaccines will no longer be universally recommended for healthy children or healthy pregnant women. That's a big shift, and understandably, it's raised a lot of questions. We're going to cut through the noise and take a look at where things really stand, who's getting vaccinated, how current guidance is evolving, and what this means for both children and adults as we look ahead to the next respiratory season.  Joining us to help sort it all out is Dr. John Schoen, Senior Clinical Manager of Drug Information at Vizient.     Guest speakers:  John Schoen, PharmD, BCPS  Senior Clinical Manager of Drug Information   Vizient Center for Pharmacy Practice Excellence    Host:  Stacy Lauderdale, PharmD, BCPS  Associate Vice President Vizient Center for Pharmacy Practice Excellence    Show Notes:  [01:38-05:32] What changed in the recent CDC update for healthy children [05:33-09:32] Discussion of COVID-19 outcomes and vaccination in children [09:33-11:47] Specific risk factors for pediatric patients [11:48-12:47] Is the US an outlier for not universally recommending the COVID-19 vaccine for healthy children and making no recommendation in healthy pregnant women? [12:48-14:03] The FDA's proposed regulatory framework for COVID-19 vaccine approval [14:04-15:18] FDA's approach to implementing revised requirements for randomized controlled trials [15:19-16:57] Key discussion points from the May meeting of the Vaccines and Related Biological Products Advisory Committee [17:00-18:27] Topics requiring further clarification about COVID-19 vaccine   Links | Resources: Vizient resources: Minute Market Insight: Potential ACIP COVID-19 recommendation changes April 2025: https://www.vizientinc.com/download?342668 Minute Market Insight: May 2025 COVID-19 vaccine recommendation and policy updates: https://www.vizientinc.com/download?352336 Additional resources: FDA perspective piece published in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMsb2506929 ACIP meeting information: https://www.cdc.gov/acip/meetings/index.html CDC childhood immunization schedule: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html CDC adult immunization schedule by medical condition: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html CDC RESP-NET: https://www.cdc.gov/resp-net/dashboard/ WHO COVID-19 dashboard: https://data.who.int/dashboards/covid19/deaths MMWR - COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged

Widespread vaccination efforts declared measles eliminated in the United States in 2000. However, recent outbreaks have reignited public health concerns. The country is experiencing a growing number of measles cases with clusters reported in several states. A highly contagious virus, measles, poses serious risks, especially to unvaccinated individuals and vulnerable patient populations. Dr. John Schoen, Senior Clinical Manager of Drug Information at the Vizient Center for Pharmacy Practice Excellence, discusses the current outbreak, measles vaccine strategies, and answers questions about prevention and public health impact with Stacy Lauderdale, Associate Vice President at the Vizient Center for Pharmacy Practice Excellence and your VerifiedRx program host.   Guest speakers:  John Schoen, Pharm.D, BCPS Senior Clinical Manager of Drug Information Vizient Center for Pharmacy Practice Excellence   Host:  Stacy Lauderdale, Pharm.D, BCPS Associate Vice President Vizient Center for Pharmacy Practice Excellence   Show Notes:  [01:12-03:30] Are we in an unprecedented situation in the United States? [03:31-05:49] A brief overview about measles [05:50-08:03] Overview of the MMR vaccine [08:04-10:15] MMR vaccination rate in the United States [10:16-12:27] Is there a link between autism and MMR vaccine [12:28-14:47] Does the MMR vaccine cause measles? [14:48-18:04] 1 vs. 2 doses of the MMR vaccine in adults [18:05-21:25] Measles postexposure prophylaxis [21:26-23:40] Vitamin A and measles   Links | Resources:  Vizient Resources Evidence Bites: 2025 Measles Outbreak Resources Measles cases and outbreaks: https://www.cdc.gov/measles/data-research/index.html 2013 MMWR measles recommendations: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6204a1.htm#Tab3 CDC measles vaccine recommendations: https://www.cdc.gov/measles/hcp/vaccine-considerations/index.html#cdc_generic_section_5-post-exposure-prophylaxis-for-measles HAN alert 2025 outbreak: https://www.cdc.gov/han/2025/han00522.html American Academy of Pediatrics recommendations: https://publications.aap.org/redbook/book/755/chapter/14079321/Measles?autologincheck=redirected Information about the MMR vaccines: https://www.cdc.gov/vaccines/vpd/mmr/hcp/about.htm   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

Drug shortages continue to pose significant challenges for hospitals and health systems. While they gained national attention during the COVID-19 pandemic, pharmacy departments have managed them for decades. During high-profile shortages, institutions must rapidly establish command centers, engage stakeholders, and implement plans for frontline staff. Once resolved, shortages often recede from immediate focus until the next crisis emerges. However, pharmacy departments consistently manage shortages on a daily basis, often without recognition. Dr. Kyle Hoelting, Sr. Clinical Manager of Drug Information and Drug Shortages at Vizient, Dr. Heather Warhurst, Director of Drug Use Policy, Quality Initiative and Regulatory at IU Health, and Dr. Chris Nagy, Medication Sourcing and Supply Pharmacist at Intermountain Health join us to discuss a Vizient workgroup project designed to measure the impact of drug shortages and highlight the crucial role of pharmacists in their management.   Guest speakers:  Heather Warhurst, Pharm.D, MHA Director of Drug Use Policy, Quality Initiative and Regulatory IU Health   Chris Nagy, Pharm.D, BCPS Medication Sourcing and Supply Pharmacist Intermountain Health   Kyle Holting, Pharm.D, BCPS Senior Clinical Manager of Drug Information Vizient Center for Pharmacy Practice Excellence   Host: Stacy Lauderdale, Pharm.D, BCPS Associate Vice President Vizient Center for Pharmacy Practice Excellence VerifiedRx Host   Show Notes:  [01:18-02:29] Heather and Chris introductions [02:30-04:00] Vizient drug shortage key performance indicators (KPI) workgroup series [04:01-10:04] Labor and Inventory drug shortage KPIs [07:50-16:56] Patient Safety and Stress to Front Line Staff drug shortage KPIs [16:57-18:32] Call to Action   Links | Resources:  Key performance indicators for the management of drug shortages   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

The widespread use of pneumococcal conjugate vaccine (PCV) in children has dramatically lowered the incidence of pneumococcal disease through direct and indirect effects. Despite this progress, pneumococcal pneumonia still leads to more than 200,000 adult hospitalizations annually in the United States. Older adults, individuals with underlying health conditions, and certain racial groups continue to experience higher rates of pneumococcal disease. Dr. John Schoen, Senior Clinical Manager of Drug Information at the Vizient Center for Pharmacy Practice Excellence, joins Program Host Stacy Lauderdale to discuss the newest adult pneumococcal vaccine, PCV21, and recent updates to age-based pneumococcal vaccine recommendations.   Guest speakers:  John Schoen, Pharm.D, BCPS Senior Clinical Manager of Drug Information Vizient Center for Pharmacy Practice Excellence   Host:  Stacy Lauderdale, Pharm.D, BCPS Associate Vice President Vizient Center for Pharmacy Practice Excellence VerifiedRx Host   Show Notes:  [01:25-02:53] Background on PCV21 [02:54-07:56] Difference between PCV20 and PCV21 [07:57-16:15] Discussing the new ACIP recommendation to move the universal age for pneumococcal vaccination from 65 years of age down to 50 years of age and older [08:31-16:15] Why a healthy 50-year-old who has no risk factors for invasive pneumococcal disease should get a pneumococcal vaccination [16:16-17:57] Summary of other changes in the most recent MMWR [17:58-19:34] What organizations consider when selecting specific pneumococcal vaccines [19:35-21:18] What's in the pipeline for  pneumococcal vaccines   Links | Resources:  Publicly available resources Previous VerifiedRx podcasts on pneumococcal vaccines: What's pneu with pneumococcal vaccines? – March 29, 2022 What's pneu part 2: pneumococcal vaccines update – February 13, 2024 January 2024 MMWR - ACIP recommendations for the use of PCV in adults ≥ 50 years of age Vizient client exclusive resources 2025 pneumococcal vaccines side-by-side comparison   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

Parents, keep an eye out for a few things that could harm your children when it comes to toys this holiday season. Pharmacist and clinical toxicologist Dr. Bryan Kuhn with Banner Poison & Drug Information Center tells us what to watch out for. 

Baxter's Intravenous Fluids North Cove Plant was impacted in September by Hurricane Helene. Although Baxter implemented a hurricane preparedness plan, a levy breach and bridge collapse forced a complete shutdown. Intravenous fluids are now on allocation as the plant remains shuttered. Multiple actions by the FDA and Baxter are in effect to improve supply for these fluids. Vizient colleagues Katie Korte, VP Assurance and Continuity Team and Kyle Hoelting, Senior Clinical Manager of Drug Information and Shortages join Stacy Lauderdale, Associate Vice president of Evidence-based Medicine today to discuss lessons learned from this and past supply disruptions, ongoing efforts by the FDA to improve supplies and the supply outlook for the next four to eight weeks   Guest speakers:  Katie Korte, PharmD, MHA VP Assurance and Continuity Team Vizient   Kyle Holting, PharmD, BCPS Senior Clinical Manager of Drug Information and Shortages Vizient Center for Pharmacy Practice Excellence   Host:  Stacy Lauderdale, PharmD, BCPS Associate Vice president of Evidence-based Medicine Vizient Center for Pharmacy Practice Excellence    Show Notes:  [00:57-01:27] Guest's background information  [01:28-04:33] Recent supply disruptions [04:34-05:54] What Vizient has learned from past disruptions [05:55-09:30] What providers have learned from these shortages [09:31-13:42] What the FDA is doing to assist with this shortage [13:43-18:23] What the trajectory of this shortage looks like over the next four to eight weeks [18:24-19:45] Most important thing to emphasize to our listeners as they continue to handle this fluid shortage   Links | Resources:  Vizient's IV push list: Click here Vizient's IV fluid conservation strategies: Click here Baxter's North Cove facility website: Click here FDA's Baxter North Cove facility website: Click here   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

phactMI, a 501 (c)(6) corporation, is a collaboration of pharmaceutical company Medical Information leaders. These Medical Information professionals provide accurate and unbiased clinical data on their products that facilitates the safe and effective use of medicines.   But where do pharmacists and other healthcare providers go for accurate information?   Join us in this episode as Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers The State University of New Jersey and guest speakers Drs. Indrani Kar, Daniel Abazia, and Jennifer Riggins discuss real world experiences in accessing drug information.  The objectives of this podcast are to: • Discuss the real-world challenges faced by healthcare professionals and how information helped them navigate the situation. • And to describe how to access information from the phactMI Drug Information Portal Learn more about phactMI at: www.phactMI.org/about/  

We emerged from the COVID -19 pandemic in 2022 to headlines about unseasonably early spikes in respiratory syncytial virus and concerns and threats of a triple pandemic of CV19, influenza, and RSV.  Fortunately, there's been no triple pandemic, but what has emerged is multiple first-time vaccine approvals for RSV. Dr. John Schoen, Senior Manager of Drug Information at The Vizient Center for Phamacy Practice Excellence joins his colleague and Program Host Stacy Lauderdale, Associate Vice President of Evidence-Based Medicine to discuss the use of the RSV vaccines.   Guest speakers:  John Schoen, PharmD, BCPS Senior Manager of Drug Information  Vizient Center for Pharmacy Practice Excellence   Host: Stacy Lauderdale, PharmD, BCPS Associate Vice President of Evidence-Based Medicine  Vizient Center for Pharmacy Practice Excellence VerifiedRx Host   Show Notes:  [00:55-01:46] John's background  [01:47 -03:15] The RSV disease burden in older adults, and risk factors [03:16-04:42] The relative disease severity of RSV versus influenza [04:43-07:04] Vaccine uptake during the last RSV season [07:05-8:35] Efficacy of the RSV vaccines in observational data compared to the clinical trials [8:36-11:22] Changes in ACIP recommendations [11:23-13:14] Potential benefits of RSV vaccination for ages older than 75 [13:15-15:32] Potential adverse reactions of RSV vaccines [15:33-18:31] Comparisons of the RSV vaccines [18:32-20:46] Are patients going to need more than one RSV vaccine?   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

On "This Week in Pharmacy" we're excited to talk about Remote Pharmacy Services with Dr. Thea Blystone, PharmD, who's built an amazing program for other entrepreneurial pharmacists out there wanting to build their own clinical consultancy. We're also talkning with Tenille Davis, the Chief Advocacy Officer for the Alliance for Pharmacy Compounding following up from our September TWIRx episode.  References:  A4PC.org --find more info on Compounding  Remote Pharmacy Services, building your business with Thea, on LinkedIn.  TWIRx News:  Did you hear aboutn "3 Houston-area pharmacy operators charged for illegally selling 70 million opioid pills" --what the heck? (from Sharron Melton, with CW39 Houston News)  American Pharmacists Month: Alan Corley Discusses Importance of Pharmacy to Patients, from Pharmacy Times  National pharmacy chain to lay off nearly 3,000 workers, from Cleveland.com News  DME Pharmacy Magazine, reports on a story titled "Pharmacy Teams Under Pressure" by Laurie Watanabe  Pharmacy Podcast Network features include:  Bruce Kneeland's 'Pharmacy CrossRoads' delivers a ROCKSTAR interview with Dr. Ken Thai and his new Group Purchasing Organization. kb-rx.com  The 3-Part Series, 'The Last Mile with RxMile' you don't want to miss this, see here:  https://www.linkedin.com/pulse/last-mile-rxmile-podcast-series-todd-s-eury-smdwe/  Breaking into Drug Information, by phactMI, newe podcast series, with Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, with phactMI and guest speakers Drs. Susan Wnoroswki, Alicia Cadogan, and Joy Yee!  Talking AI and the Evolution of Personalized Medicine, from the CEO of the NASP, Shelia Arquette with special guest Stuart Kamin, SVP of Analytics and Innovation at Claritas Rx.  It's time to TWIRx, get your moves on while you listen to 'This Week in Pharmacy' 

phactMI, a 501 (c)(6) corporation, is a collaboration of pharmaceutical company Medical Information leaders. These Medical Information professionals provide accurate and unbiased clinical data on their products that facilitates the safe and effective use of medicines. But who are Medical Information professionals and what do they really do?  Join us in this episode as Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers The State University of New Jersey and guest speakers Drs. Susan Wnoroswki, Alicia Cadogan, and Joy Yee discuss their background as Medical Information professionals, the role of Medical Information in providing scientifically accurate information, and the day in a life of a Medical Information Professional.  Learn more about phactMI at: www.phactMI.org/about/

phactMI, a 501 (c)(6) corporation, is a collaboration of pharmaceutical company Medical Information leaders. These Medical Information professionals provide accurate and unbiased clinical data on their products that facilitates the safe and effective use of medicines.  Medical information doubles every 73 days. It is difficult to both keep up with the overwhelming amount of information and to distinguish the good from the bad. Misinformation is real and is something that everyone, especially pharmacists who are the front line information source, need to be aware of.  Join us in this episode as Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers The State University of New Jersey and guest speakers Drs. Daniel Shindler, Christie Denton, and Jane Orper as they discuss the power of accurate drug information, the risks of misinformation, and the role that Medical Information from the pharmaceutical industry can play.  The objectives for this podcast are: • Identify the challenges of keeping up to date with drug information • Discuss the consequences of misinformation in healthcare • Describe Medical Information from pharma as one resource for up to date, scientifically balanced information

A generous ghost/A mountain mystery/Two visions of the future!   Patreon https://www.patreon.com/user?u=18482113 PayPal Donation Link https://tinyurl.com/mrxe36ph MERCH STORE!!! https://tinyurl.com/y8zam4o2 Amazon Wish List https://www.amazon.com/hz/wishlist/ls/28CIOGSFRUXAD?ref_=wl_share Help Promote Dead Rabbit! Dual Flyer https://i.imgur.com/OhuoI2v.jpg "As Above" Flyer https://i.imgur.com/yobMtUp.jpg “Alien Flyer” By TVP VT U https://imgur.com/gallery/aPN1Fnw “QR Code Flyer” by Finn https://imgur.com/a/aYYUMAh Links: The Shadowlands Maine (Houlton, Maine Money Flies Out Window Ghost story) https://www.theshadowlands.net/places/maine.htm Archive https://archive.ph/Qq2GT The deadly danger of 'dewshine' https://www.tennessean.com/story/news/2016/01/27/deadly-danger-dewshine-teens-tennessee/79401368/ Canned Heat Blues (Remastered) https://www.youtube.com/watch?v=RHw1ugBLS5g&ab_channel=TommyJohnson-Topic I learned how to drink Sterno https://www.dfwstangs.net/threads/i-learned-how-to-drink-sterno.377672/ Sterno https://en.wikipedia.org/wiki/Sterno The Place Of Scary - Haunted Places https://hauntedplacesofusa.blogspot.com/2009/09/paddy-holler-foxcroft-cemetery.html Haunted Places In Maine https://americasmosthaunted.blogspot.com/2009/10/haunted-places-in-maine_18.html I'm freaked out (Woman Sees Motorcycle On Side Of Road Next Day Man Dies In Motorcycle Accident Sees Future story) https://www.reddit.com/r/Paranormal/comments/1cno28z/im_freaked_out/ Archive https://archive.ph/DlEW6 Seroquel Side Effects (Generic Name: Quetiapine) https://greenhousetreatment.com/what-is-seroquel/long-term-effects/ Zoloft (sertraline) Drug Information https://www.rxresource.org/consumer-information/zoloft.html I have had something similar happen (Woman Sees Mummy Decayed Corpse Driving Car Friend Dies In Car Accident Later story) https://www.reddit.com/r/Paranormal/comments/1cno28z/comment/l38r2a9/ Archive https://archive.ph/fpuLh (Youtube Will Not Let Me Include Links To The Subreddit lol) ------------------------------------------------ Logo Art By Ash Black Opening Song: "Atlantis Attacks" Closing Song: "Bella Royale" Music By Simple Rabbitron 3000 created by Eerbud Thanks to Chris K, Founder Of The Golden Rabbit Brigade Dead Rabbit Archivist Some Weirdo On Twitter AKA Jack YouTube Champ Stewart Meatball The Haunted Mic Arm provided by Chyme Chili Forever Fluffle: Samson, Cantillions Discord Mods: Mason, HotDiggityDane, Carson   http://www.DeadRabbit.com Email: DeadRabbitRadio@gmail.com Twitter: https://twitter.com/DeadRabbitRadio Facebook: www.Facebook.com/DeadRabbitRadio TikTok: https://www.tiktok.com/@deadrabbitradio Dead Rabbit Radio Subreddit: https://www.reddit.com/r/DeadRabbitRadio/ Paranormal News Subreddit: https://www.reddit.com/r/ParanormalNews/ Mailing Address Jason Carpenter PO Box 1363 Hood River, OR 97031 Paranormal, Conspiracy, and True Crime news as it happens! Jason Carpenter breaks the stories they'll be talking about tomorrow, assuming the world doesn't end today. All Contents Of This Podcast Copyright Jason Carpenter 2018 - 2024  

The incredible staying power of drug shortages kicks the door open for full-time pharmacy roles designed to combat this issue. Dr. Austin Pytlowany, clinical pharmacist specialist in drug shortage management at Michigan Medicine and Vizient's Kyle Hoelting, senior clinical manager of drug shortages and drug information join host Gretchen Brummel, Pharmacy Executive Director with the Vizient Center for Pharmacy Practice Excellence to discuss drug shortages and drug information and share their perspectives.   Guest speakers:  Austin Pytlowany, PharmD Pharmacy Manager – Inventory and Drug Shortage Management Michigan Medicine Kyle Hoelting, PharmD, BCPS Sr. Clinical Manager of Drug Information and Shortages Vizient Center for Pharmacy Practice Excellence  Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Show Notes:  [00:48-01:53] Dr. Pytlowany background information  [01:54-02:52] Why Michigan Medicine created his position [02:53-05:52] The overall impact of drug shortages right now [05:53-07:12] National impact of drug shortages [07:13-10:41] Austin's position helping improving patient care at Michigan Medicine [10:42-12:25] Organizational benefits of individuals or a teams dedicated to drug shortages [12:26-16:41] Other kinds of positions out there [16:42-20:40] Concepts and solutions coming out of this or to market [20:41-22:11] Future for these types of roles in drug shortages [22:12-25:38] Advice for people who want to get into this specialty   Links | Resources:  The One Thing You Need to Know about Drug Shortage Stewardship Drug Shortage Stewardship: Calls to Action for the Interconnected Supply Chain ASHP Current Drug Shortages   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed      

Dr. Theresa Michele, MD from the Office of Nonprescription Drugs within the FDA's Center for Drug Evaluation and Research and Dr. Ilisa Bernstein, PharmD Senior Vice President for Practice, Policy and Partnerships from the American Pharmacists Association, APhA, are our guests on this episode of "Q&A with FDA" Q&A with FDA provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA's Division of Drug Information will answer some of the most commonly asked questions received by FDA. Perhaps you have had the same questions but never asked. C.E. for this episode here: https://www.fda.gov/drugs/news-events-human-drugs/qa-fda-podcastRSS feed for Q&A with FDA

InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that's been garnering a lot of views from our users right now is which atypical antipsychotics are associated with the lowest and highest risk of QT prolongation.

Pneumococcal vaccines have been instrumental in decreasing invasive disease since their introduction in the 1980s. 2021 brought regulatory changes and recent ACIP recommendations were published in the Morbidity and Mortality Weekly Report, also known as MMWR. Dr. John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information shares his insights on these changes with host Gretchen Brummel.      Guest speakers:   John Schoen, PharmD, BCPS Senior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Practice Excellence      Host:   Gretchen Brummel, PharmD, BCPS   Pharmacy Executive Director   Vizient Center for Pharmacy Practice Excellence     Show Notes:   Recorded in the Fall of 2023 [01:00-03:34] What's new since March 2022 with pneumococcal vaccines  [03:35-06:51] Changes with the adult recommendations [06:52-13:10] New recommendations from CDC as well as published recommendations for adults [13:11-19:05] Recommendations for Pneumococcal vaccines in pediatrics [19:06-21:46] The area of biggest risk moving forward [21:47-24:07] What we are looking at for the future        Links | Resources:   Vizient pneumococcal vaccine side-by-side comparison Click Here ACIP pneumococcal vaccine recommendations Click Here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed

This week, Natalie and Julian unpack the healthy and unhealthy habits they've experienced since starting work in the turf industry. Kassidy was whisked away last minute to work the 2024 Sentry Tournament of Champions in Kapalua and was unfortunately unable to join in live, BUT we still made sure to get her take on her habits during her tournament week! And you know the saying, when the Kass is away, the mice, they play! This weeks episode is jam packed with laughs, ridiculous questions, and we end by tackling an issue near and dear to our hostesses hearts. CONTENT WARNING: This episode contains conversation about alcohol and substance abuse. If you or anyone you know is struggling, we have included resources below: SAMHSA: National Hotline: 800-662-HELP (4357) Alberta Addiction Help Line: 1-866-332-2322 British Colombia (Alcohol and Drug Information and Referral Service):1-800-663-1441 & 604-660-9382 http://www.samhsa.gov/find-help/national-helpline http://www.americanaddictionscenters.org http://www.usa.gov/substance-abuse http://www.nationalrehabhotline.org/resources/relapse-prevention/ http://www.ccsa.ca/addictions-treatments-helplines-canada

The Michigan Poison & Drug Information Center at Wayne State University warns of laced drugs after a rash of overdoses, including a mass overdose event last week in Calhoun County. WWJ's Luke Sloan has more.  No injuries after a DDOT bus crashed on Detroit's east side. WWJ's Charlie Langton has more. (Credit: WWJ/Charlie Langton)

Join Ashlee as she talks with Derek Borkowski, CEO and founder of Pyrls about the journey that led to the creation of Pyrls. Alongside this, Derek discusses Pyrls' partnership with CEimpact and the future of Pyrls  as a company.Pyrls is an online drug information provider that focuses on design and simplicity in their delivery of that information. Through an deeper dive into Pyrls, this episode offers up an exclusive behind-the-scenes glimpse into the future of digital health and the role of technology in the medical field.  In this episode, the two discuss:- The creation of Pyrls - Pyrls' impact on the healthcare world- Pyrls' partnership with CEimpact- The future of Pyrls To learn more about CEimpact's By Design memberships, click here. Follow CEimpact on Social Media:LinkedInInstagramDownload the CEimpact App for Free Continuing Education + so much more!

Have you ever come up with a helpful idea for yourself that also could provide value to others? That's the story of Pyrls, a new player in the drug information space. Derek Borkowski identified a personal need for a streamlined resource to identify appropriate counseling points for patients in the community pharmacy. With a lot of grit, the acquisition of new skills, and the right teammates, Derek's idea of "drug information made easy" transformed into a web-based and mobile app solution trusted by pharmacists, physicians, physician associates, nurse practitioners, nurses, dentists, and professional students. Listen as we hear Derek tell the story of Pyrls, the lessons he has learned along the way, and his thoughts about how technological innovation will continue to transform drug information and the practice of pharmacy in the future.

CURE ID is an internet-based repository that allows the global community to report novel uses of existing drugs for difficult-to-treat diseases through a website, a smartphone, or other mobile device. In this episode, FDA's Division of Drug Information interviews Ms. Heather Stone, FDA's health science policy analyst in the FDA's Office of Medical Policy, and Dr. Marco Schito, Executive Director of the Critical Path Institute's CURE Drug Repurposing Collaboratory, or CDRC to discuss the benefits and future of CURE ID.

Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic.  Episode-2 looks at the safety and efficacy of lecanemab in the treatment of Alzheimer's dementia.

A lost boy's story to find their way home. www.coastmentalhealth.com MENTAL HEALTH RESOURCES CANADIAN RESOURCES: · Canadian Mental Health Association (Talk Suicide) -1-833-456-4566 · Wellness Together Canada · 24/7 Counsellor Line- 1-866-585-0445 · Hope for Wellness Indigenous Line - 1-855-242-3310 · ADULT Immediate Crisis Support - Text WELLNESS to 741741 · YOUTH Immediate Crisis Support - Text WELLNESS to 686868 · Indian Residential School Crisis Line - 1-866-925-4419 · Kid's Help Phone - 1-800-668-6868 BC RESOURCES: · BC Crisis Line - 1-800-SUICIDE (1-800-784-2433) · 310Mental Health Support - 310-6789 (no area code needed) · Alcohol & Drug Information and Referral Service - 1-800-663-1441 · Care to Speak - 1-866-802-7337 · Kelty Mental Health Resource Centre - 1-800-665-1822 · Kuu-Us Crisis Line Society (crisis services for Indigenous people across BC) · ADULT LINE - (250) 723-4050 · YOUTH LINE – (250) 723-2040 · Métis Crisis Line - 1-833-MétisBC (1-833-638-4722) · HealthLink BC – 811 (to speak with a nurse any time of the day or night) Please call 911 for Urgent mental health or substance use concerns. If you feel you or someone else might be in danger of hurting themselves or someone else, call 9-1-1 or go to the nearest hospital emergency department right away.

Former NHL goal tender and mental health advocate Corey Hirsch introduces the podcast series by describing the Mental Health Act in BC, involuntary commitment and the need for wrap around mental health services. www.coastmentalhealth.com MENTAL HEALTH RESOURCES CANADIAN RESOURCES: · Canadian Mental Health Association (Talk Suicide) -1-833-456-4566 · Wellness Together Canada · 24/7 Counsellor Line- 1-866-585-0445 · Hope for Wellness Indigenous Line - 1-855-242-3310 · ADULT Immediate Crisis Support - Text WELLNESS to 741741 · YOUTH Immediate Crisis Support - Text WELLNESS to 686868 · Indian Residential School Crisis Line - 1-866-925-4419 · Kid's Help Phone - 1-800-668-6868 BC RESOURCES: · BC Crisis Line - 1-800-SUICIDE (1-800-784-2433) · 310Mental Health Support - 310-6789 (no area code needed) · Alcohol & Drug Information and Referral Service - 1-800-663-1441 · Care to Speak - 1-866-802-7337 · Kelty Mental Health Resource Centre - 1-800-665-1822 · Kuu-Us Crisis Line Society (crisis services for Indigenous people across BC) · ADULT LINE - (250) 723-4050 · YOUTH LINE – (250) 723-2040 · Métis Crisis Line - 1-833-MétisBC (1-833-638-4722) · HealthLink BC – 811 (to speak with a nurse any time of the day or night) Please call 911 for Urgent mental health or substance use concerns. If you feel you or someone else might be in danger of hurting themselves or someone else, call 9-1-1 or go to the nearest hospital emergency department right away.

The frustration of desperately asking for help but being denied services due to appearing too "functional". www.coastmentalhealth.com MENTAL HEALTH RESOURCES CANADIAN RESOURCES: · Canadian Mental Health Association (Talk Suicide) -1-833-456-4566 · Wellness Together Canada · 24/7 Counsellor Line- 1-866-585-0445 · Hope for Wellness Indigenous Line - 1-855-242-3310 · ADULT Immediate Crisis Support - Text WELLNESS to 741741 · YOUTH Immediate Crisis Support - Text WELLNESS to 686868 · Indian Residential School Crisis Line - 1-866-925-4419 · Kid's Help Phone - 1-800-668-6868 BC RESOURCES: · BC Crisis Line - 1-800-SUICIDE (1-800-784-2433) · 310Mental Health Support - 310-6789 (no area code needed) · Alcohol & Drug Information and Referral Service - 1-800-663-1441 · Care to Speak - 1-866-802-7337 · Kelty Mental Health Resource Centre - 1-800-665-1822 · Kuu-Us Crisis Line Society (crisis services for Indigenous people across BC) · ADULT LINE - (250) 723-4050 · YOUTH LINE – (250) 723-2040 · Métis Crisis Line - 1-833-MétisBC (1-833-638-4722) · HealthLink BC – 811 (to speak with a nurse any time of the day or night) Please call 911 for Urgent mental health or substance use concerns. If you feel you or someone else might be in danger of hurting themselves or someone else, call 9-1-1 or go to the nearest hospital emergency department right away.

A journey of finding the middle path between their unique reality and the shared reality, Anne takes you through their experience with the mental health system and finding groundedness in the shared reality. www.coastmentalhealth.com MENTAL HEALTH RESOURCES CANADIAN RESOURCES: · Canadian Mental Health Association (Talk Suicide) -1-833-456-4566 · Wellness Together Canada · 24/7 Counsellor Line- 1-866-585-0445 · Hope for Wellness Indigenous Line - 1-855-242-3310 · ADULT Immediate Crisis Support - Text WELLNESS to 741741 · YOUTH Immediate Crisis Support - Text WELLNESS to 686868 · Indian Residential School Crisis Line - 1-866-925-4419 · Kid's Help Phone - 1-800-668-6868 BC RESOURCES: · BC Crisis Line - 1-800-SUICIDE (1-800-784-2433) · 310Mental Health Support - 310-6789 (no area code needed) · Alcohol & Drug Information and Referral Service - 1-800-663-1441 · Care to Speak - 1-866-802-7337 · Kelty Mental Health Resource Centre - 1-800-665-1822 · Kuu-Us Crisis Line Society (crisis services for Indigenous people across BC) · ADULT LINE - (250) 723-4050 · YOUTH LINE – (250) 723-2040 · Métis Crisis Line - 1-833-MétisBC (1-833-638-4722) · HealthLink BC – 811 (to speak with a nurse any time of the day or night) Please call 911 for Urgent mental health or substance use concerns. If you feel you or someone else might be in danger of hurting themselves or someone else, call 9-1-1 or go to the nearest hospital emergency department right away.

An interview highlighting the ups and downs of psychiatric care while integrating ones own self identity. www.coastmentalhealth.com MENTAL HEALTH RESOURCES CANADIAN RESOURCES: · Canadian Mental Health Association (Talk Suicide) -1-833-456-4566 · Wellness Together Canada · 24/7 Counsellor Line- 1-866-585-0445 · Hope for Wellness Indigenous Line - 1-855-242-3310 · ADULT Immediate Crisis Support - Text WELLNESS to 741741 · YOUTH Immediate Crisis Support - Text WELLNESS to 686868 · Indian Residential School Crisis Line - 1-866-925-4419 · Kid's Help Phone - 1-800-668-6868 BC RESOURCES: · BC Crisis Line - 1-800-SUICIDE (1-800-784-2433) · 310Mental Health Support - 310-6789 (no area code needed) · Alcohol & Drug Information and Referral Service - 1-800-663-1441 · Care to Speak - 1-866-802-7337 · Kelty Mental Health Resource Centre - 1-800-665-1822 · Kuu-Us Crisis Line Society (crisis services for Indigenous people across BC) · ADULT LINE - (250) 723-4050 · YOUTH LINE – (250) 723-2040 · Métis Crisis Line - 1-833-MétisBC (1-833-638-4722) · HealthLink BC – 811 (to speak with a nurse any time of the day or night) Please call 911 for Urgent mental health or substance use concerns. If you feel you or someone else might be in danger of hurting themselves or someone else, call 9-1-1 or go to the nearest hospital emergency department right away.

A look into multiple diagnoses, living with changed realities, and having to navigate mental health systems. www.coastmentalhealth.com MENTAL HEALTH RESOURCES CANADIAN RESOURCES: · Canadian Mental Health Association (Talk Suicide) -1-833-456-4566 · Wellness Together Canada · 24/7 Counsellor Line- 1-866-585-0445 · Hope for Wellness Indigenous Line - 1-855-242-3310 · ADULT Immediate Crisis Support - Text WELLNESS to 741741 · YOUTH Immediate Crisis Support - Text WELLNESS to 686868 · Indian Residential School Crisis Line - 1-866-925-4419 · Kid's Help Phone - 1-800-668-6868 BC RESOURCES: · BC Crisis Line - 1-800-SUICIDE (1-800-784-2433) · 310Mental Health Support - 310-6789 (no area code needed) · Alcohol & Drug Information and Referral Service - 1-800-663-1441 · Care to Speak - 1-866-802-7337 · Kelty Mental Health Resource Centre - 1-800-665-1822 · Kuu-Us Crisis Line Society (crisis services for Indigenous people across BC) · ADULT LINE - (250) 723-4050 · YOUTH LINE – (250) 723-2040 · Métis Crisis Line - 1-833-MétisBC (1-833-638-4722) · HealthLink BC – 811 (to speak with a nurse any time of the day or night) Please call 911 for Urgent mental health or substance use concerns. If you feel you or someone else might be in danger of hurting themselves or someone else, call 9-1-1 or go to the nearest hospital emergency department right away.

Dr. James Braun, Neurosciences Pharmacy Clinical Specialist at SSM Health St. Louis, and Dr. Kyle Hoelting, Senior Manager of Drug Information at Vizient, continue to share their insights on the use of TNK vs Alteplase for treating acute ischemic stroke. They also discuss the nuances of this therapeutic area and share recent work from an expert panel led by Vizient.   Guest speakers: James Braun, PharmD, BCCCP Neurosciences Pharmacy Clinical Specialist  SSM Health   Kyle Hoelting, PharmD, BCPS Senior Manager of Drug Information  Vizient   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:30-3:59] Medication safety risks associated with thrombolytics [04:00-4:42] Using one drug over another [04:43-6:48] How frontline pharmacy staff can utilize this information [06:49-11:44] What Vizient can add to the discussion [11:45-11:55] When report will be released   Links | Resources: Tenecteplase vs alteplase in acute ischemic stroke: Vizient expert panel Verified Rx: Evidenced based medicine Click here Verified Rx: Show me the data! Updates on the evidence of thrombolytic use in ischemic strokes Click here Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 1 Click here Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 2 Click here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed

This is the second time we have had the James Booth Foundation  and the Oklahoma Center for Poison and Drug Information on the program, but there is always more to learn!  Laura Brennan, the State Education Coordinator along with Kristie Edlen, the Assistant Managing Director from the Oklahoma Center for Poison and Drug information share some valuable information! In the second segment. Willie Edwards, Director of Community Assessment for Feed the Children explains his connection to James Booth. Jalisha Booth, founder of the James Booth Foundation.org is on hand, as well as Joseph Mitchell, a current student at Putnam City Original.See omnystudio.com/listener for privacy information.

Dr. James Braun, Neurosciences Pharmacy Clinical Specialist at SSM Health St. Louis, and Dr. Kyle Hoelting, Senior Manager of Drug Information at Vizient, share their insights on the use of tenecteplase vs alteplase for treating acute ischemic stroke. They also discuss the nuances of this therapeutic area and share recent work from an expert panel led by Vizient.   Guest speakers: James Braun, PharmD, BCCCP Neurosciences Pharmacy Clinical Specialist  SSM Health   Kyle Hoelting, PharmD, BCPS Senior Manager of Drug Information  Vizient   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:58-3:00] James' background and his role in the treatment of stroke patients [03:01-5:09] History of tenecteplase and alteplase for ischemic stroke [05:10-6:56] Information about trials of alteplase [06:57-8:11] Where Tenecteplase fits in discussion [08:12-9:51] Differences with tenecteplase and alteplase to clinicians [9:52-12:00] What studies say about potential, practical advantages of tenecteplase [12:01-19:55] Making the switch between agents   Links | Resources: Verified Rx: Evidenced based medicine Click here Verified Rx: Show me the data! Updates on the evidence of thrombolytic use in ischemic strokes Click here Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 1 Click here Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 2 Click here Identifying errors and safety considerations in patients undergoing thrombolysis in acute ischemic stroke Click here EXTEND-IA TNK Click here Australian-TNK Click here Meta-analysis NIHSS outcomes Click here NOR-TEST Click here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed

Today, we're talking about IMLYGIC® (talimogene laherparepvec or T-VEC).  In my pronunciation episodes, I say a brand drug name and its generic, break both drug names down into syllables, explain which syllable or syllable(s) have the emphasis, reveal the source(s) of my information, and put the written pronunciations of both in the show notes so that you see them and use them right away. The purpose of these pronunciation episodes is to provide the intended pronunciations of drug names from reliable sources. I want you to feel confident saying drug names and less frustrated learning them.   Thank you for listening to episode 159 of The Pharmacist's Voice ® Podcast! To read the full show notes, visit https://www.thepharmacistsvoice.com.  Click on the podcast tab, and search for episode 159.   What is IMLYGIC® (talimogene laherparepvec)?  It's a treatment for a skin cancer called melanoma. IMLYGIC® = imm LY jik (I prefer to write it imm LYE jik.) Verbal/audio pronunciation source:  IMLYGIC® Healthcare Provider Video Written pronunciation source:  IMLYGIC® medication guide on the FDA's website https://www.fda.gov/media/94135/download    T-VEC = T-VEC Pronunciation sources:  none   talimogene laherparepvec = tal IM oh jeen la HER pa REP vek Verbal/audio pronunciation source:  IMLYGIC® Healthcare Provider Video Written pronunciation source:  USP Dictionary Online If you can't access the USP Dictionary Online for a written generic drug name pronunciation, and the drug name wasn't mentioned verbally in a video published by the drug sponsor, you can also call the drug sponsor's drug information department, and ask for help (during normal business hours).  Another option is calling the Division of Drug Information at the FDA's Center for Drug Evaluation and Research during normal business hours.  Calling either may sound intimidating, but if you're a voice actor, and you need to get it right, do the right thing.  Use reliable sources; put drug names into your own words; and say them with confidence.  You can do this! When you can see and hear a drug name pronunciation, it will be easier for you to say.  If you like easy, get both!  If YOU'RE interested in picking a drug name for a future pronunciation episode, please visit www.thepharmacistsvoice.com, and click the contact tab.  Either leave me a voicemail message or type out a written message using the contact form.  I'd love to hear from you! If you know someone who would like this episode or needs to hear it, please share it with them.   Thank you for listening to The Pharmacist's Voice ® Podcast Episode 159!   Thank you USP Legal Department for permission to use written pronunciations from the USP Dictionary Online in my YouTube videos and podcast show notes. Mentioned in this episode The Pharmacist's Voice Podcast Episode 155/Pronunciation Episode 5 The Pharmacist's Voice Podcast Episode Pronunciation 148/Episode 4 The Pharmacist's Voice Podcast Episode 142/Pronunciation Episode 3 The Pharmacist's Voice Podcast Episode 138/Pronunciation Episode 2 The Pharmacist's Voice Podcast Episode 134/Pronunciation Episode 1 IMLYGIC® website (accessed 6-26-22) https://www.imlygic.com  IMLYGIC® Healthcare Provider Video (you can hear the pronunciation of IMLYGIC) IMLYGIC® medication guide on the FDA's website https://www.fda.gov/media/94135/download (you can see the pronunciation of IMLYGIC) Medication Guide tab on IMLYGIC's website USP Dictionary Online (USAN) sales page (you can see the written pronunciation of talimogene laherparepvec.  Division of Drug Information at the FDA/CDER (look at the “Contact Us” section)

We have two different organizations as usual this week. Our first guests are from The Oklahoma Housing Finance Agency https://www.ohfa.org/ We talked about their work in helping people buy or rent homes. The Oklahoma Center for Poison and Drug Information brought two representatives to discuss their hotline and home hazards.https://oklahomapoison.org/See omnystudio.com/listener for privacy information.

About Helen Stevenson Helen is the Founder and CEO of Reformulary Group Inc. Helen was Assistant Deputy Minister of Health in Ontario and Executive Officer of Ontario Public Drug Programs by Order-In-Council. About Reformulary Group Inc. Our mission is to make drugs more affordable for Canadians. We do that through an innovative approach by creating a subscription-based service. --- Support this podcast: https://anchor.fm/tbcy/support

Additional resources OHA COVID-19 vaccine website: covidvaccine.oregon.gov OHA Facebook  Safe+Strong website Ask a Black Doctor on The Numberz REACH webpage and REACH Facebook Treatments for COVID-19 Q1: I have heard that some people can get treated for COVID-19. What treatments are available and how are they different from vaccines? Yes – treatments for COVID-19 are available for some people. Some treatments are given in the hospital, some are infusions and some are pills you can take at home. They are all in short supply and currently available to people who are high risk of severe disease.  Vaccines introduce your immune system to a protein from the virus, allowing you to build up antibodies without being infected. Vaccination can also boost any natural immunity a person may have from being previously infected.  When somebody with sufficient antibodies is exposed to COVID-19, they immediately fend off the virus, which prevents infection. As antibody levels drop, the virus may be able to infect the person but the immune system still has a decent chance to fight COVID-19 and prevent severe infection.  Booster shots rebuild antibodies quickly, within a few days, even quicker than the original vaccination. This rapid rebuild also happens when an unvaccinated person previously infected with the COVID-19 virus gets their first vaccination. So be sure to get vaccinated and boosted, even if you have previously been infected with COVID-19. Treatments do not replace vaccination, which remains the most important step we can take to protect ourselves and our loved ones.  If someone can't get vaccinated, there is a treatment available that helps the body fight the virus that causes COVID-19.  Treatment for COVID-19 must take place shortly after someone has tested positive. If you've tested positive for COVID or have symptoms, contact your doctor right away. Q2: Someone was telling me about the federal Test to Treat program. Is this a program for everyone? The Test to Treat program connects people that are at high risk of severe illness from COVID-19 with the right treatment. It provides people a place to go to get tested, receive a prescription for a treatment, and fill that prescription all at one location. The program is intended for people that do not have a doctor or who cannot easily get in to see their doctor. However, anyone can receive treatment at a Test to Treat site. To participate, a person can use the Test to Treat Locator to find a site, or call 1-800-232-0233. These sites receive their therapeutics from the federal government. OHA is working on adding additional sites that fit federal criteria to be a Test to Treat site.   Q3: If treatments support defense against COVID-19, why aren't they available to everyone? There a few reasons why treatments are not available to everyone. First, vaccines have proven to be the best defense against COVID-19. Get vaccinated and then boosted. Also, don't forget your flu shot. Secondly, because of nationwide shortages, treatments are not widely available. Finally, it is all based on eligibility. A healthcare provider determines eligibility based on your medical profile. They will consider things like if you cannot get vaccinated due to health conditions or if you had a bad reaction to the vaccine or if you need additional treatment due to a weakened immune system. Only a healthcare provider can assess if you are eligible. Q3: Are treatments safe?  Depending on your medical history, certain treatments are not recommended. To determine which treatment is right for you, consult your doctor. You should also always check that your information is from a trusted source. If you have questions about any medication, contact the FDA's Division of Drug Information at 301-796-3400 or druginfo@fda.hhs.gov. Q5: What are the names of the FDA approved or authorized treatments and once I take them, how do they work in my body to fight COVID-19? The FDA has authorized two oral antiviral medications, one from Pfizer named Paxlovid. The other from Merck named Molnupiravir. With either one, they must be taken as soon as possible after a positive COVID-19 test and within the first five days of symptoms to be effective.  Paxlovid works by stoping the replication of the COVID-19 virus in the body by binding to an enzyme that disrupts the virus' ability to mutate and keeps certain viral proteins from forming correctly.   Molnupiravir interrupts replication of the virus' genetic material by introducing mutations. As the virus copies itself, it gets so mutated that it can no longer function.   The same thing happens with the FDA approved antiviral drug Remdesivir, known as Veklury, it also acts on the virus' genetic material, blocking its ability to mutate. It is administered by injection into the vein through an IV. Monoclonal antibodies (mAbs) are authorized for use to treat COVID-19. They work by mimicking the antibodies your body produces in response to a virus. These molecules are produced in a laboratory and they work to block the COVID-19 virus from entering your cells. Monoclonal antibody treatment is a fluid given using a needle either into a vein (infusion) or under the skin (subcutaneously). Your healthcare provider or the site where you will be getting treatment will explain which treatment you will get. For both procedures, needles are used by a trained medical professional. If you are unvaccinated, you should wait 90 days after your treatment to get the vaccine. Regen-Cov, Sotrovimab, Bebtelovimab and Evusheld are all monoclonal antibodies. Sotrovimab is effective against infection by the  Omicron variant.  Q6: Finally, April is National Minority Health Month how can I get involved? This year the U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH) and its partners are highlighting the important role community plays in helping to reduce health disparities in racial and ethnic minority and American Indian/Alaska Native groups. The theme for this year is Give Your Community a Boost!  To support COVID-19 vaccination and boosting, OMH invites you to #BoostYourCommunity by using, sharing, and attending National Minority Health Month (NMHM) resources and events with your organization, communities, and network!  If you are not insured, you might qualify for the Oregon Health Plan, which covers COVID-19 vaccines, boosters, treatment and home tests. It also covers regular check-ups, prescriptions, mental health care, addiction treatment, dental care and more. To see if you qualify and to learn more go to OHP.Oregon.gov and click Apply for OHP. You can also call 800-699-9075 or find a local community partner at bit.ly/ohplocalhelp for help.Document accessibility: For individuals with disabilities or individuals who speak a language other than English, OHA can provide information in alternate formats such as translations, large print, or braille. Contact the Health Information Center at 1-971-673-2411, 711 TTY or COVID19.LanguageAccess@dhsoha.state.or.us.

John Schoen, Senior Clinical Manager of Drug Information, at Vizient, shares his insights on the history and current state of pneumococcal vaccines within the practitioner community. He also discusses the complexity of ACIP recommendations after the recent addition of two newer vaccines, PCV 20 and PCV 15, and what the future holds for the vaccines.   Guest speaker: John Schoen, PharmD, BCPS Senior Clinical Manager of Drug Information  Vizient   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:51-1:51] John's background [01:52-4:22] Pneumococcal vaccines history and current [04:23-7:30] Significance of vaccines [07:31-9:33] What's new with Pneumococcal vaccines [09:34-12:00] How expanded serotype coverage changes things [12:01-15:37] Efficacy data points from recent studies [15:38-16:26] Safety concerns from trials [16:27-18:51] Current ACIP recommendations [18:52-23:10] How to deal with the different combinations of vaccines [23:11-24:37] Safety implications of vaccine combinations [24:38-25:43] How frontline staff positions itself for appropriate support [25:44-27:50] What to expect for the future of pneumococcal immunizations   Links | Resources: Side-by-side comparison for the pneumococcal vaccines Public access link: Click Here Member only (comprehensive) link: Click Here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed

Some people have no idea what Pharmacists do. Maybe, that's because pharmacists do so many things. Today's guest, Derek Borkowski, is a pharmacist, software engineer, and the founder and CEO of Cosmas Health.Derek is also the creator of Pyrls - a popular new drug information website used by over 10,000 clinicians and students. He graduated from the University of Minnesota with his PharmD in 2018 and started working in community pharmacy until he fell in love with technology.From pharmacist to software engineer to founder, Derek shares his journey from leaving his community pharmacy job to pursuing entrepreneurship full-time, moving to San Francisco for an accelerator program, and getting VC funding.

Stacy Lauderdale, Senior Director of Drug Information, and Kyle Hoelting, Senior Manager of Drug Information at Vizient, share their insights on the history and current state of evidence-based medicine within the practitioner community. They also discuss how to reverse the trend of using anecdotal experience and swing the pendulum back to increased reliance on evidenced based medicine.   Guest speakers: Stacy Lauderdale, PharmD, BCPS Senior Director of Drug Information  Vizient   Kyle Hoelting, PharmD, BCPS Senior Manager of Drug Information  Vizient   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:55-2:18] Kyle and Stacy's backgrounds [02:19-3:45] Evidence Based Medicine definition and history [03:46-5:54] Current state of EBM [05:55-10:45] Basic tools of EBM [10:46-14:29] Difference between clinical and statistical significance [14:30-15:56] Outcomes   [15:57-18:28] Role of FDA in promoting EBM [18:29-20:27] How pharmacy and therapeutics committees incorporate EBM [20:28-21:15] EBM Resources   Links | Resources: Seigfried RJ, Corbo T, Saltzberg MT, Reitz J, Bennett DA. Deciding which drugs get onto the formulary: a value-based approach Value Health. 2013 Jul-Aug;16(5):901-6.   Riegelman RK, Nelson BA. Studying a Study & Testing a Test: Reading Evidence-Based Health Research. Philadelphia: Wolters Kluwer; 2021.   Gehlbach SH. Interpreting the Medical Literature. 5th ed. New York: McGraw Hill; 2006.   Malone PM, Malone MJ, Park SK. Drug information: a guide for pharmacists. 6th ed. New York:  McGraw Hill; 2014.   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed

On today's episode I will be speaking with two guests i've never met before. They gave me their opinions on certain topics and I took in what information I didn't know. Enjoy!

Renu Lal, PharmD, is a Team Lead in the Division of Drug Information (DDI) within the Food and Drug Administration/Center for Drug Evaluation and Research/Office of Communications. Along with directly communicating with the public, the Division is responsible for many initiatives and outreach programs such as the CDER Small Business and Industry Assistance (SBIA) Program;  FDA Drug Info Rounds video;  Drug Safety podcasts;  Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.), Webinars for healthcare professionals and students, and more.  Renu is an officer in the Commissioned Corps of the U.S. Public Health Service (U.S. PHS), a uniformed service committed to protecting, promoting, and advancing the health and safety of the nation. Mentioned in this episode United States Public Health Service (U.S. PHS) JRCOSTEP and SRCOSTEP Programs for students Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)  FDA Drug Safety Podcasts Small Business and Industry Assistance (SBIA) Chronicles Podcast FDA Drug Info Rounds Video Series Webinars for healthcare professionals and students UCONN School of Pharmacy Medical University of South Carolina College of Pharmacy   The University of Toledo College of Pharmacy  U.S. Department of Health and Human Services Indian Health Service BOP (Federal Bureau of Prisons) NIH (National Institutes of Health) CDC (Centers for Disease Control and Prevention) FDA (Food and Drug Administration) EPA (Environmental Protection Agency) SAMSHA (Substance Abuse and Mental Health Services Administration) CDERLearn (CDER Learn Training and Education) Subscribe to or Follow The Pharmacist's Voice Podcast! Apple Podcasts Google Podcasts Spotify Amazon/Audible Read the full show notes at The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast Dr. Renu Lal's path from pharmacy school to the U.S. Public Health Service was not a direct one.  She earned her BS Degree in Pharmacy from UCONN in 1998.  Then, she earned her Post-Bac PharmD from the Medical University of South Carolina in Charleston in 2000.  Renu did not know what she wanted to do with her PharmD when she graduated.  According to Renu, “It's ok to not know and make it up as you go along.”  She spent time in community practice as a floater, then entered the U.S. PHS.  Her PHS service was interrupted briefly when she left PHS to join a clinical regulatory team at Genentech in San Francisco, CA.  When that role ended, she rejoined PHS.  As of October 2021, her total service time is approximately 10 years.   While in her undergrad program at UCONN, Renu learned about PHS.  A speaker from the Indian Health Service spoke to her class.  After finishing her BS Degree in Pharmacy, Renu joined the U.S. PHS as a JRCOSTEP and completed a paid, 4-month rotation at a Psych Hospital in SE DC called St. Elizabeth's Hospital. She loved the experience and thought it was amazing!  Students can join either the JRCOSTEP Program or the SRCOSTEP Program.  Both are paid positions with benefits.  Visit https://www.usphs.gov/students/ to learn more.   During our conversation, I talked about my experience with PHS at the Federal Bureau of Prisons.  I did an 8-week rotation at FCI Milan during the last semester of my BS Pharm Degree program at The University of Toledo College of Pharmacy in 2001.  My pharmacist in charge was creative and resourceful, and she did amazing things with a small formulary.  I learned a lot from her and that experience.  I wanted to join the Navy upon graduation, but I was medically disqualified due to asthma. The United States Public Health Service (U.S. PHS) is led by the Surgeon General of the U.S. and is more than 200 years old.  It is one of eight uniformed services and is the only one dedicated solely to protecting and advancing America's Public Health.  As a U.S. PHS Officer, Renu is first in line to defend America from public health threats, including deploying for public health emergencies.  She has deployed many times and provided essential healthcare to underserved and vulnerable populations.  The U.S. Public Health Service used to be “pharmacy's best kept secret,” but that's not true anymore because PHS has played a prominent role in response to COVID.  As a PHS Officer, there is an opportunity to serve in many HHS (U.S. Department of Health and Human Services) agencies.  Examples include IHS (Indian Health Service), BOP (Federal Bureau of Prisons), NIH (National Institutes of Health), CDC (Centers for Disease Control and Prevention), FDA (Food and Drug Administration), EPA (Environmental Protection Agency), SAMSHA (Substance Abuse and Mental Health Services Administration), and others.  Being an Officer makes it easy to transfer among agencies. According to Renu, PHS Officer benefits are great!  They are on the military pay scale with paid vacation, retirement benefits (with minimum of 20 years of service), medical benefits, the GI Bill and more.  To learn more about age restrictions and eligibility requirements to serve, visit https://www.usphs.gov.   Resources that DDI (Department of Drug Information) offers SBIA Program Free Conferences and Webinars Podcasts   FDA Drug Safety Podcasts Drug Information Soundcast in Clinical Oncology “D.I.S.C.O.”   SBIA Chronicles (trending regulatory topics) Drug Info Rounds educational videos featuring DDI pharmacists   CDER Learn - portal for all CE activities.  Webinars and podcasts are there.   We concluded the interview with Renu's advice for currently-practicing or newly graduated pharmacists:  Do and learn what interests you, and the rest will fall into place.   Thank you for listening to The Pharmacist's Voice ® Podcast Episode 123!

Dr. Mark Yarema, Alberta Poison and Drug Information Service  See omnystudio.com/listener for privacy information.

Trygve Anderson, VP of Commercial Pharmacy, Elsevier and Dale Whitby, Editor in Chief for Drug Information, Elsevier, discuss how pharmacists are increasing their role at every step in the retail and virtual patient journey. Dale is a passionate pharmacist in her own right and on this podcast, she breaks down four areas of discussion: Symptom Research including Telehealth and Clinical Visits The Pharmacy Visit The Consultation The impact of pharmacy on medication adherence Host: Trygve Anderson, Elsevier's Vice President, Commercial – Pharmacy Guest: Dale Whitby, Elsevier's Editor in Chief for Drug Information Learn more on Elsevier's Website Follow on Twitter | Facebook | LinkedIn | YouTube

Adam Best had a lot of responsibility when he was in the Navy. After 5 years of being in the military, he had to learn who he was. While he stayed in a civilian position with the Navy, he still had to figure where his life was headed. He talked to me about the positive and negative about his transition, and we also discuss his battle with alcohol.  His Veterans in the Wild Podcast will be launching on May 27, 2021. Find the podcast @veteransinthewild on IG, YouTube!  **************** If you are dealing with any type of addiction, there is help for not only you but your family. Here are some links below.Alcoholics Anonymous (AA) www.aa.org 212–870–3400 or check your local phone directory under “Alcoholism”Moderation Management www.moderation.org212–871–0974Secular Organizations for Sobriety www.sossobriety.org 323–666–4295SMART Recovery www.smartrecovery.org 440–951–5357Women for Sobriety www.womenforsobriety.org 215–536–8026Groups for family and friendsAl-Anon Family Groups www.al-anon.alateen.org 1–888–425–2666 for meetingsAdult Children of Alcoholics www.adultchildren.org310–534–1815Information resourcesNational Institute on Alcohol Abuse and Alcoholism www.niaaa.nih.gov 301–443–3860National Institute on Drug Abuse www.nida.nih.gov 301–443–1124National Institute of Mental Health www.nimh.nih.gov 1–866–615–6464National Clearinghouse for Alcohol and Drug Information www.samhsa.gov 1–800–729–6686--- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app--- Send in a voice message: https://anchor.fm/d-m-needom/messageSupport this podcast: https://anchor.fm/d-m-needom/supportSupport the show

Finding sobriety can be life changing especially if you are headed in a direction of destruction, alcoholism and unhealthy living. This podcast is with a very special guest. Special guest Rebecca talks about her journey with alcoholism and finding sobriety. How she came to the conclusion it was time to get help. When hitting rock bottom happens, or docent happen. Not only does she speak on her experience as a recovering alcoholic but she shares her story of breaking the generational curses as a parent. What do we as parents when our children are now walking down the wrong path. During this pandemic there are less resources but they are still out there. If you are looking help please following resources below. Chakras.Cusswords@yahoo.com I IG: Chakras.Cusswords I FB: Chakras.Cusswords  Medical and non-medical addiction specialists American Academy of Addiction Psychiatry www.aaap.org  401–524–3076 American Psychological Association  www.apa.org  1–800–964–2000 (ask for your State's referral number to find psychologists with addiction specialties) American Society of Addiction Medicine  www.asam.org  301–656–3920 (ask for the phone number of your State's chapter) NAADAC Substance Abuse Professionals  www.naadac.org  1–800–548–0497 National Association of Social Workers www.helpstartshere.org (search for social workers with addiction specialties) Treatment facilities Substance Abuse Treatment Facility Locator  www.findtreatment.samhsa.gov  1–800–662–HELP Mutual-support groups Alcoholics Anonymous (AA)  www.aa.org  212–870–3400 or check your local phone directory under “Alcoholism” Moderation Management  www.moderation.org 212–871–0974 Secular Organizations for Sobriety  www.sossobriety.org  323–666–4295 SMART Recovery  www.smartrecovery.org  440–951–5357 Women for Sobriety  www.womenforsobriety.org  215–536–8026 Groups for family and friends Al-Anon Family Groups  www.al-anon.alateen.org  1–888–425–2666 for meetings Adult Children of Alcoholics  www.adultchildren.org 310–534–1815 Information resources National Institute on Alcohol Abuse and Alcoholism  www.niaaa.nih.gov  301–443–3860 National Institute on Drug Abuse  www.nida.nih.gov  301–443–1124 National Institute of Mental Health  www.nimh.nih.gov  1–866–615–6464 National Clearinghouse for Alcohol and Drug Information  www.samhsa.gov  1–800–729–6686 --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/chakrascusswords/message

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay.What are Non Official Drug Information sources? Can they serve as Secondary sources of drug information? All this and much related to this particular topic of discussion will be measured in leaps and bounds in today's episode.If Official drug compendia serves as Primary source, then definitely Non official drug compendia serves as Secondary source of drug information. i will start my talk with comments on Martindale, also known as Extrapharmacopoeia.It is published by the Royal Pharmaceutical society of Great Britain and is the Complete Drug Reference. It includes data of all drugs, approved/registered all over the globe. The information is unbiased, reliable  and complete. You can refer to it for complete pharmacological profile and pharmaceutical bearing of the drug.Next I will be listing  more of non official publications which includes lot of drug details , trade names along with generic names. Its shared thoroughly , legally unrestricted. The main ones are AMA, PDR, Modern Drug Encyclopaedia.So that was in short a quick coverage and important details on Non Official Drug Compendia.What next you should get to know about, something like drug nature and from where is it exactly derived, yes!! surely that gonna harbinger my next episode. For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. What are Non Official Drug Information sources? Can they serve as Secondary sources of drug information? All this and much related to this particular topic of discussion will be measured in leaps and bounds in today's episode. If Official drug compendia serves as Primary source, then definitely Non official drug compendia serves as Secondary source of drug information. i will start my talk with comments on Martindale, also known as Extrapharmacopoeia.It is published by the Royal Pharmaceutical society of Great Britain and is the Complete Drug Reference. It includes data of all drugs, approved/registered all over the globe. The information is unbiased, reliable and complete. You can refer to it for complete pharmacological profile and pharmaceutical bearing of the drug.Next I will be listing more of non official publications which includes lot of drug details , trade names along with generic names. Its shared thoroughly , legally unrestricted. The main ones are AMA, PDR, Modern Drug Encyclopaedia. So that was in short a quick coverage and important details on Non Official Drug Compendia. What next you should get to know about, something like drug nature and from where is it exactly derived, yes!! surely that gonna harbinger my next episode. For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. What are Non Official Drug Information sources? Can they serve as Secondary sources of drug information? All this and much related to this particular topic of discussion will be measured in leaps and bounds in today's episode. If Official drug compendia serves as Primary source, then definitely Non official drug compendia serves as Secondary source of drug information. i will start my talk with comments on Martindale, also known as Extrapharmacopoeia.It is published by the Royal Pharmaceutical society of Great Britain and is the Complete Drug Reference. It includes data of all drugs, approved/registered all over the globe. The information is unbiased, reliable and complete. You can refer to it for complete pharmacological profile and pharmaceutical bearing of the drug.Next I will be listing more of non official publications which includes lot of drug details , trade names along with generic names. Its shared thoroughly , legally unrestricted. The main ones are AMA, PDR, Modern Drug Encyclopaedia. So that was in short a quick coverage and important details on Non Official Drug Compendia. What next you should get to know about, something like drug nature and from where is it exactly derived, yes!! surely that gonna harbinger my next episode. For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay.Does your textbook cover all the minute details, I mean all, everything like trade names, drug information, purity, chemical, physical characteristics, etc? Well, if not, in today's episode you will get the knowledge of drug information sources, especially official ones.The collective term used for drug literature is "Drug Compendia". When I say its official, it means that government supervises it. The two main Official Drug Compendia are Pharmacopeia and Formulary.Pharmacopoeia is supervised in a country by a set of chosen physicians. It covers drug details like chemical structure and properties, physical properties and molecular weight, assay techniques, drug preservation and storage methods, etc. Such a kind of information is very useful for drug regulators and drug manufacturers. Its hardly of any use to the clinical practitioners. Some well known ones are IP (Indian pharmacopoeia), BP (British pharmacopoeia), USP (United States Pharmacopoeia)Next, I want to talk about Formulary, its supervised in a land by set of pharmacists. Very useful information like drug use indications, drug dose, dosage form, cautions, contraindications, side effects and much more is covered in this. Description of drug class precedes the discussion of drug itself. Some well known examples are British National Formulary (BNF), National Formulary of India (NFI). With this chit chat about Official Drug Compendia, next topic to be discussed is Non Official Drug Compendia, surely to be in next episode...I will be call it for the day, Wishing you all a great , safe weekend!! For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. Does your textbook cover all the minute details, I mean all, everything like trade names, drug information, purity, chemical, physical characteristics, etc? Well, if not, in today's episode you will get the knowledge of drug information sources, especially official ones.The collective term used for drug literature is "Drug Compendia". When I say its official, it means that government supervises it. The two main Official Drug Compendia are Pharmacopeia and Formulary. Pharmacopoeia is supervised in a country by a set of chosen physicians. It covers drug details like chemical structure and properties, physical properties and molecular weight, assay techniques, drug preservation and storage methods, etc. Such a kind of information is very useful for drug regulators and drug manufacturers. Its hardly of any use to the clinical practitioners. Some well known ones are IP (Indian pharmacopoeia), BP (British pharmacopoeia), USP (United States Pharmacopoeia) Next, I want to talk about Formulary, its supervised in a land by set of pharmacists. Very useful information like drug use indications, drug dose, dosage form, cautions, contraindications, side effects and much more is covered in this. Description of drug class precedes the discussion of drug itself. Some well known examples are British National Formulary (BNF), National Formulary of India (NFI). With this chit chat about Official Drug Compendia, next topic to be discussed is Non Official Drug Compendia, surely to be in next episode...I will be call it for the day, Wishing you all a great , safe weekend!! For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. Does your textbook cover all the minute details, I mean all, everything like trade names, drug information, purity, chemical, physical characteristics, etc? Well, if not, in today's episode you will get the knowledge of drug information sources, especially official ones.The collective term used for drug literature is "Drug Compendia". When I say its official, it means that government supervises it. The two main Official Drug Compendia are Pharmacopeia and Formulary. Pharmacopoeia is supervised in a country by a set of chosen physicians. It covers drug details like chemical structure and properties, physical properties and molecular weight, assay techniques, drug preservation and storage methods, etc. Such a kind of information is very useful for drug regulators and drug manufacturers. Its hardly of any use to the clinical practitioners. Some well known ones are IP (Indian pharmacopoeia), BP (British pharmacopoeia), USP (United States Pharmacopoeia) Next, I want to talk about Formulary, its supervised in a land by set of pharmacists. Very useful information like drug use indications, drug dose, dosage form, cautions, contraindications, side effects and much more is covered in this. Description of drug class precedes the discussion of drug itself. Some well known examples are British National Formulary (BNF), National Formulary of India (NFI). With this chit chat about Official Drug Compendia, next topic to be discussed is Non Official Drug Compendia, surely to be in next episode...I will be call it for the day, Wishing you all a great , safe weekend!! For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay.How Drug therapy evolved? What are the sources of drug information? Responses to these fireshot questions will be given in today's episode.Ancient Mesopotamian, Indian, Chinese, Egyptian records emphasized the disease nature to be something supernatural, a bad omen, Then greek mythology of four humors of body changed this belief and made patient the main focus. Development of science in a rapid manner proved all diseases affected different organs, so this lead to the main centre of research to be disease. Then came Microscope invention, all in all importance of drug therapy was gaining importance and demanded in depth knowledge and clinical skill and expertise. Drugs could prove both harmful and useful. Next I will be shifting my discussions towards Sources of Drug Information , I would broadly classify these in Primary, Secondary and Tertiary. Primary being original source of information. Secondary referring to review articles. tertiary is nothing but mix of both, summary embedded in text format. I will be giving a valuable tip to do research or find a query response, it goes as, start from tertiary to secondary to primary , i.e. backway or reverse order and it will maximise your quest in a simplified, easy, convenient and organised manner. With this great tip to study, research and memorise, I will be hinting the next episode content and call it for the day. For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. How Drug therapy evolved? What are the sources of drug information? Responses to these fireshot questions will be given in today's episode. Ancient Mesopotamian, Indian, Chinese, Egyptian records emphasized the disease nature to be something supernatural, a bad omen, Then greek mythology of four humors of body changed this belief and made patient the main focus. Development of science in a rapid manner proved all diseases affected different organs, so this lead to the main centre of research to be disease. Then came Microscope invention, all in all importance of drug therapy was gaining importance and demanded in depth knowledge and clinical skill and expertise. Drugs could prove both harmful and useful. Next I will be shifting my discussions towards Sources of Drug Information , I would broadly classify these in Primary, Secondary and Tertiary. Primary being original source of information. Secondary referring to review articles. tertiary is nothing but mix of both, summary embedded in text format. I will be giving a valuable tip to do research or find a query response, it goes as, start from tertiary to secondary to primary , i.e. backway or reverse order and it will maximise your quest in a simplified, easy, convenient and organised manner. With this great tip to study, research and memorise, I will be hinting the next episode content and call it for the day. For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. How Drug therapy evolved? What are the sources of drug information? Responses to these fireshot questions will be given in today's episode. Ancient Mesopotamian, Indian, Chinese, Egyptian records emphasized the disease nature to be something supernatural, a bad omen, Then greek mythology of four humors of body changed this belief and made patient the main focus. Development of science in a rapid manner proved all diseases affected different organs, so this lead to the main centre of research to be disease. Then came Microscope invention, all in all importance of drug therapy was gaining importance and demanded in depth knowledge and clinical skill and expertise. Drugs could prove both harmful and useful. Next I will be shifting my discussions towards Sources of Drug Information , I would broadly classify these in Primary, Secondary and Tertiary. Primary being original source of information. Secondary referring to review articles. tertiary is nothing but mix of both, summary embedded in text format. I will be giving a valuable tip to do research or find a query response, it goes as, start from tertiary to secondary to primary , i.e. backway or reverse order and it will maximise your quest in a simplified, easy, convenient and organised manner. With this great tip to study, research and memorise, I will be hinting the next episode content and call it for the day. For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine. It actually contains lot of updates about the medical sciences, drug information and my podcast updates also. You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!

PNM#11 - Jami Johnson Jami Johnson is a Medical Science Liaison for BTG Specialty Pharmaceuticals and an Adjunct Assistant Professor at the University of Oklahoma College of Pharmacy. Prior to her move to industry, she was the Assistant Managing Director of the Oklahoma Center for Poison and Drug Information. She completed undergraduate coursework at the University of Oklahoma in Norman prior to completing the Doctorate of Pharmacy Program at the University of Oklahoma College of Pharmacy. Dr. Johnson worked as a Poison Information Provider at the OCPDI while completing her PharmD, which initially sparked her interest in toxicology. After graduation, she completed the Clinical Toxicology and Emergency Medicine Fellowship Program at UFHealth-Jacksonville and the Florida Poison Information Center-Jacksonville. Upon completion of her fellowship, she obtained certification as a Diplomate of the American Board of Applied Toxicology. When she isn't MSLing, she enjoys donating her time to various professional organizations, most recently joining the ABAT NACCT 2019 Symposium committee and participating in AACT's Clinical Toxicology Recommendations Collaborative Activated Charcoal project on the systematic review committee and clinical recommendations panel. She is dedicated to continued professional improvement and growth, mostly recently joining the OU Health Sciences Center's 2019 Leadership Council. Her professional interests include critical care with an emphasis on cardiotoxicity, and natural toxins, especially venomous snakes. Her personal interests include avoiding the aforementioned natural toxins in the wild and spending time with her friends and family. BOOMER SOONER! In this episode: Toxicology training for pharmacists - fellowship vs residency ABAT examination - becoming a DABAT Snakes, antivenom and all things toxicology! --- Support this podcast: https://anchor.fm/empharmd/support

In this episode, Trygve Anderson and Dale Whitby discuss the value of drug information during uncertain times in the podcast, Drug information on the frontline of the COVID-19 pandemic. This podcast also highlights the ongoing efforts of Elsevier in providing valuable information regarding the COVID-19 pandemic to frontline stakeholders. This episode is the first of a three part series. Host: Trygve Anderson is Elsevier's Vice President, Commercial – Pharmacy. Guest: Dale Whitby is Elsevier's Editor in Chief – Drug Information. Learn more on Elsevier's Website Follow on Twitter | Facebook | LinkedIn | YouTube

Every use on online service? Ever need to use one but did not? What role do they play? Are they helpful? Why do they exist?

Welcome to the Pharmaguy episode 111 "Pharmacy Podcast Show" who created the ®. (aka, John Mack), and is the creator of Pharma Marketing Blogand the publisher of Pharma Marketing News. Follow @Pharmaguy™ on Twitter and Facebook.Pharma Marketing NetworkPharmaguy™ John Mack, President of VirSci Corporation, is an experienced executive with a background in pharmaceutical marketing communications, interactive technologies, and medical privacy. Mr. Mack is currently a principal consultant with VirSci Corporation, where he provides global pharmaceutical and health care industry clients with marketing communications, competitive market intelligence, and privacy/security consulting services. Previously, Mr. Mack was a consultant in the Life Sciences Practice at Answerthink, where he managed projects such as pharmaceutical DTC and physician web site development, privacy policy assessments, and HIPAA awareness workshops for healthcare providers. Mr. Mack also created and managed PharmInfoNet, a privately owned "Top 20 Health Site" focused on drug information content and databases for physicians and pharmacists. In 1999, he sold this web site to Mediconsult and became their Director of Drug Information. Mr, Mack is Publisher and Editor of  and moderates the PHARMA-MKTING on-line discussion Forum, both essential components of the Pharma Marketing Network.Pharma Marketing News See omnystudio.com/listener for privacy information.